Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Clinical Trials
•
Pediatric Oncology
•
Oncology
What are the main barriers you encounter in enrolling pediatric oncology patients on clinical trials?
Related Questions
Which oral chemotherapy regimen do you use in relapsed fusion positive rhabdomyosarcoma?
What is your approach to patients/parents seeking alternative or complementary treatment in pediatric oncology patients?
How would you manage moderate eosinophilia (~2-3k) with no evidence of end organ damage?
How do you approach revaccination after chemotherapy, and what labs (if any) do you use to assess immune reconstitution?
For what patients/diagnoses do you currently use sodium thiosulfate to reduce the risk of cisplatin associated ototoxicity?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
How do you approach adjuvant therapy for resected Stage I Ewing sarcoma of the kidney?
What workup do you complete for a teenage patient presenting with an incidentally discovered adrenal mass?
Do you use prophylactic defibrotide in pediatric patients undergoing BMT who are considered to be at high risk for the development of VOD/SOS?
In platinum-refractory or multiply-relapsed NSGCT with 1–2 progressive sites and no good surgical option, is there a role for local radiotherapy (e.g., SBRT) to those sites?
